concise.news
SearchSign inGet the Brief
Story
‹ Story 9

Story tools

FDA requires GLP-1 drugs to warn about potential vision loss risk.

Compare

How each outlet told it.

  1. SourceSTATUnited StatesLeanCenterCredibilityRatings: AllSides, MBFCRead at STAT“STAT+: FDA warns GLP-1 drugs carry potential risk of rare eye condition”1 h 55 min later
  2. SourceMarketWatchUnited StatesOwner: Dow Jones & CompanyLeanCenterCredibilityRatings: AllSides, MBFCRead at MarketWatch“Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss”59 min later
  3. SourceQuartzUnited StatesLeanUnratedCredibilityUnratedRead at Quartz“FDA is requiring weight loss drug makers to add a vision loss warning”1 h 30 min later
  4. SourceThe IndependentUnited KingdomLeanCenter-leftCredibilityRatings: AllSides, MBFCRead at The Independent“FDA adds rare vision-loss warning to popular GLP-1 drugs”6 min later
  5. SourceAP NewsUnited StatesLeanCenterCredibilityRatings: AllSides, MBFCRead at AP News“FDA adds rare vision-loss warning to popular GLP-1 drugs”23 min later
  6. SourceThe Washington PostUnited StatesLeanCenter-leftCredibilityRatings: AllSides, MBFCRead at The Washington Post“FDA tells GLP-1 makers to warn of potential vision loss side effect”2 min later
  7. SourceNew York PostUnited StatesLeanCenter-rightCredibilityRatings: AllSides, MBFCRead at New York Post“GLP-1 drugs must have new warning label over incurable blindness condition, says FDA”55 min later
  8. SourceGizmodoUnited StatesLeanUnratedCredibilityUnratedRead at Gizmodo“FDA Orders New Vision Loss Warning for Ozempic and Other GLP-1s”2 h 23 min later
  9. SourceCBS NewsUnited StatesLeanUnratedCredibilityUnratedRead at CBS News“FDA warns of rare vision-loss side effect from GLP-1 drugs”

In both headlinesTimes in UTC

Another view

Reliable reporting from a different lean.

No other view yet. Only center-left, center and center-right outlets are covering this story.

RatingsAllSides and Media Bias/Fact CheckLean and credibility are curated from their public ratings.Unknown outlets stay unrated, never guessed.

Citations

What it cites, and what cites it.

None.

Corrections

None.

Mentioned with

Nothing yet.

How each outlet told it.

  1. SourceSTATUnited StatesLeanCenterCredibilityRatings: AllSides, MBFCRead at STAT“STAT+: FDA warns GLP-1 drugs carry potential risk of rare eye condition”1 h 55 min later
  2. SourceMarketWatchUnited StatesOwner: Dow Jones & CompanyLeanCenterCredibilityRatings: AllSides, MBFCRead at MarketWatch“Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss”59 min later
  3. SourceQuartzUnited StatesLeanUnratedCredibilityUnratedRead at Quartz“FDA is requiring weight loss drug makers to add a vision loss warning”1 h 30 min later
  4. SourceThe IndependentUnited KingdomLeanCenter-leftCredibilityRatings: AllSides, MBFCRead at The Independent“FDA adds rare vision-loss warning to popular GLP-1 drugs”6 min later
  5. SourceAP NewsUnited StatesLeanCenterCredibilityRatings: AllSides, MBFCRead at AP News“FDA adds rare vision-loss warning to popular GLP-1 drugs”23 min later
  6. SourceThe Washington PostUnited StatesLeanCenter-leftCredibilityRatings: AllSides, MBFCRead at The Washington Post“FDA tells GLP-1 makers to warn of potential vision loss side effect”2 min later
  7. SourceNew York PostUnited StatesLeanCenter-rightCredibilityRatings: AllSides, MBFCRead at New York Post“GLP-1 drugs must have new warning label over incurable blindness condition, says FDA”55 min later
  8. SourceGizmodoUnited StatesLeanUnratedCredibilityUnratedRead at Gizmodo“FDA Orders New Vision Loss Warning for Ozempic and Other GLP-1s”2 h 23 min later
  9. SourceCBS NewsUnited StatesLeanUnratedCredibilityUnratedRead at CBS News“FDA warns of rare vision-loss side effect from GLP-1 drugs”

In both headlinesTimes in UTC